Cargando…
Sarcopenia: burden and challenges for public health
Sarcopenia, operationally defined as the loss of muscle mass and muscle function, is a major health condition associated with ageing, and contributes to many components of public health at both the patient and the societal levels. Currently, no consensual definition of sarcopenia exists and therefor...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373245/ https://www.ncbi.nlm.nih.gov/pubmed/25810912 http://dx.doi.org/10.1186/2049-3258-72-45 |
_version_ | 1782363308330844160 |
---|---|
author | Beaudart, Charlotte Rizzoli, René Bruyère, Olivier Reginster, Jean-Yves Biver, Emmanuel |
author_facet | Beaudart, Charlotte Rizzoli, René Bruyère, Olivier Reginster, Jean-Yves Biver, Emmanuel |
author_sort | Beaudart, Charlotte |
collection | PubMed |
description | Sarcopenia, operationally defined as the loss of muscle mass and muscle function, is a major health condition associated with ageing, and contributes to many components of public health at both the patient and the societal levels. Currently, no consensual definition of sarcopenia exists and therefore it is still a challenge to establish the actual prevalence of sarcopenia or to establish the direct and indirect impacts of sarcopenia on public health. Anyway, this geriatric syndrome represents a huge potential public health issue because of its multiple clinical and societal consequences. Moreover, all these aspects have an impact on healthcare costs both for the patient and the society. Therefore, the implementation of effective and broadly applicable preventive and therapeutic interventions has become a medical and societal challenge for the growing number of older persons affected by sarcopenia and its disabling complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/2049-3258-72-45) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4373245 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43732452015-03-26 Sarcopenia: burden and challenges for public health Beaudart, Charlotte Rizzoli, René Bruyère, Olivier Reginster, Jean-Yves Biver, Emmanuel Arch Public Health Commentary Sarcopenia, operationally defined as the loss of muscle mass and muscle function, is a major health condition associated with ageing, and contributes to many components of public health at both the patient and the societal levels. Currently, no consensual definition of sarcopenia exists and therefore it is still a challenge to establish the actual prevalence of sarcopenia or to establish the direct and indirect impacts of sarcopenia on public health. Anyway, this geriatric syndrome represents a huge potential public health issue because of its multiple clinical and societal consequences. Moreover, all these aspects have an impact on healthcare costs both for the patient and the society. Therefore, the implementation of effective and broadly applicable preventive and therapeutic interventions has become a medical and societal challenge for the growing number of older persons affected by sarcopenia and its disabling complications. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/2049-3258-72-45) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-18 /pmc/articles/PMC4373245/ /pubmed/25810912 http://dx.doi.org/10.1186/2049-3258-72-45 Text en © Beaudart et al.; licensee BioMed Central. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Beaudart, Charlotte Rizzoli, René Bruyère, Olivier Reginster, Jean-Yves Biver, Emmanuel Sarcopenia: burden and challenges for public health |
title | Sarcopenia: burden and challenges for public health |
title_full | Sarcopenia: burden and challenges for public health |
title_fullStr | Sarcopenia: burden and challenges for public health |
title_full_unstemmed | Sarcopenia: burden and challenges for public health |
title_short | Sarcopenia: burden and challenges for public health |
title_sort | sarcopenia: burden and challenges for public health |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373245/ https://www.ncbi.nlm.nih.gov/pubmed/25810912 http://dx.doi.org/10.1186/2049-3258-72-45 |
work_keys_str_mv | AT beaudartcharlotte sarcopeniaburdenandchallengesforpublichealth AT rizzolirene sarcopeniaburdenandchallengesforpublichealth AT bruyereolivier sarcopeniaburdenandchallengesforpublichealth AT reginsterjeanyves sarcopeniaburdenandchallengesforpublichealth AT biveremmanuel sarcopeniaburdenandchallengesforpublichealth |